×
Hero Background

MEA Diabetes Companies

ID: MRFR/Pharma/2185-HCR
65 Pages
Rahul Gotadki
October 2025

Leaders in metabolic health, Diabetes companies focus on comprehensive solutions. From research and development to patient care, these organizations specialize in therapies and technologies designed to manage diabetes effectively. Their commitment lies in advancing treatment options, improving quality of life, and addressing the growing global challenge of diabetes.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the MEA Diabetes Market

Middle East And Africa Diabetes Treatment Key Companies

 

Latest Middle East And Africa Diabetes Treatment Companies Update


AI-powered diabetes management tools Companies like WellDoc and Glooko are developing AI-powered apps and platforms that help patients track blood sugar levels, analyze trends, and personalize treatment plans.


Abbott partners with BeatO, Healthifyme, Pharmeasy, Sugar.fit, and Fitterfly collaboration provides patients with wider access to Abbott's FreeStyle Libre CGM systems in India, a key market within the MEA region.


Merck & Daiichi Sankyo join forces $22 billion collaboration will focus on developing and commercializing three promising ADC candidates, potentially expanding treatment options for diabetic patients with complications.


List of Middle East And Africa Diabetes Treatment Key Companies in the Market



  • Abbott

  • Bayer AG

  • Becton Dickinson and Company

  • Johnson & Johnson Services, Inc.

  • Merck & Co., Inc.

  • Novartis AG

  • Novo Nordisk A/S

  • Roche Diabetes Care, Inc.

  • Sanofi Avnetis U.S. LLC.

  • Ypsomed